| MDL | - |
|---|---|
| Molecular Weight | 285.26 |
| Molecular Formula | C13H14F3N3O |
| SMILES | NC(C)(C)C1=NC=C(C2=CC=C(OC(F)(F)F)C=C2)N1 |
PF-04885614 is a potent NaV1.8 inhibitor, extracted from patent US2018328915. PF-04885614 has potential for neurological and neurodevelopmental diseases treatment [1] .
Solid
Room temperature in continental US; may vary elsewhere.
| Powder | -20°C | 3 years |
|---|---|---|
| 4°C | 2 years | |
| In solvent | -80°C | 6 months |
| -20°C | 1 month |
DMSO : 250 mg/mL ( 876.39 mM ; Need ultrasonic)
| Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
|---|
| 1 mM | 3.5056 mL | 17.5279 mL | 35.0557 mL |
| 5 mM | 0.7011 mL | 3.5056 mL | 7.0111 mL |
| 10 mM | 0.3506 mL | 1.7528 mL | 3.5056 mL |